검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | mFOLFOX6 |
Overview Company | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) |
Overview Modality | ADC |
Overview Target | HER2 |
Overview Indication | Non-Small Cell Lung Cancer; NSCLC |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
MoA Mechanism | target trough concentration (C trough ) for an anti-fibroblast growth factor receptor |
MoA Biomarker | biomarkers (neurotensin, superoxide dismutase, interleukin-6), the National Cancer Institute Common Terminolo |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Impact of home-based port infusion versus hospital-based peripheral infusion on anxiety, quality of life, and emergency visits in gastrointestinal cancer: a prospective observational study by the Turkish Oncology Group (TOG).. Home-based chemotherapy via port catheters offers logistical and potential psychological benefits but may pose unique challenges for patients undergoing prolonged regimens s… |
Clinical Primary efficacy | ORR 54% |
Clinical ORR | 54% |
Clinical Result source | ClinicalTrials.gov NCT01913639 |
Clinical Data Tier / Score | A · 53 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 9일 (5일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | mFOLFOX6 |
Overview Company | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) |
Overview Modality | ADC |
Overview Target | HER2 |
Overview Indication | Non-Small Cell Lung Cancer; NSCLC |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
MoA Mechanism | target trough concentration (C trough ) for an anti-fibroblast growth factor receptor |
MoA Biomarker | biomarkers (neurotensin, superoxide dismutase, interleukin-6), the National Cancer Institute Common Terminolo |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Impact of home-based port infusion versus hospital-based peripheral infusion on anxiety, quality of life, and emergency visits in gastrointestinal cancer: a prospective observational study by the Turkish Oncology Group (TOG).. Home-based chemotherapy via port catheters offers logistical and potential psychological benefits but may pose unique challenges for patients undergoing prolonged regimens s… |
Clinical Primary efficacy | ORR 54% |
Clinical ORR | 54% |
Clinical Result source | ClinicalTrials.gov NCT01913639 |
Clinical Data Tier / Score | A · 53 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 9일 (5일 전) |
추천 비교
추천 비교